The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N5-(3-methylbenzyl)-2-(3,5-dimethoxyphenyl)-[1,2,4]-triazolo-[1,5-a][1,3,5]-triazine-5,7-diamine ID: ALA4765035
PubChem CID: 162661502
Max Phase: Preclinical
Molecular Formula: C20H21N7O2
Molecular Weight: 391.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(OC)cc(-c2nc3nc(NCc4cccc(C)c4)nc(N)n3n2)c1
Standard InChI: InChI=1S/C20H21N7O2/c1-12-5-4-6-13(7-12)11-22-19-24-18(21)27-20(25-19)23-17(26-27)14-8-15(28-2)10-16(9-14)29-3/h4-10H,11H2,1-3H3,(H3,21,22,23,24,25,26)
Standard InChI Key: USUFCKMTQNVGNK-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
29.3968 -24.7427 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.3957 -25.5622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1037 -25.9712 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.1019 -24.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8106 -24.7391 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.8154 -25.5577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5954 -25.8062 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0727 -25.1410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5876 -24.4816 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0995 -23.5166 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.8899 -25.1362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3001 -25.8426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1165 -25.8382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5218 -25.1275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1046 -24.4199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2896 -24.4279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5065 -23.7084 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.6877 -25.9703 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.9803 -25.5611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2722 -25.9691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5656 -25.5578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8581 -25.9652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8570 -26.7832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5693 -27.1922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2740 -26.7825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5289 -26.5437 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.1242 -27.2536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3237 -23.7007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1509 -25.5557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
8 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
15 17 1 0
2 18 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
13 26 1 0
26 27 1 0
17 28 1 0
22 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 391.44Molecular Weight (Monoisotopic): 391.1757AlogP: 2.71#Rotatable Bonds: 6Polar Surface Area: 112.48Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.31CX Basic pKa: 1.54CX LogP: 3.98CX LogD: 3.98Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.52Np Likeness Score: -1.41
References 1. Grieco I,Bissaro M,Tiz DB,Perez DI,Perez C,Martinez A,Redenti S,Mariotto E,Bortolozzi R,Viola G,Cozza G,Spalluto G,Moro S,Federico S. (2021) Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems., 216 [PMID:33721670 ] [10.1016/j.ejmech.2021.113331 ]